Inovio Pharmaceuticals Inc

INO

NASDAQ. Currency in USD

1.56 -0.24 ( -13.33% )

Real time prices: December 19

Market Cap.
389.20M
Beta (5Y monthly)
1.01
Price/Earnings
-
EPS (TTM)
-1.47
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Sep 29, 2017
Volume
4.37M
1y Target Est.
2.25
Day's Range
1.55
-
1.79
52 Week's Range
1.38
-
4.28

Historical Summary

Performance
EPS growth
Share Buybacks

About Inovio Pharmaceuticals Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://www.inovio.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
210.39M
Employees
317
Address
660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

Latest news

Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket

Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM...
By Benzinga - 6 weeks ago

3 Stocks to Avoid Right Now
3 Stocks to Avoid Right Now

Even though many stocks have fallen sharply in price, not all are bargains -- investors...
By The Motley Fool - 10 weeks ago

Buying Biotech Penny Stocks? 3 Things to Look For 
Buying Biotech Penny Stocks? 3 Things to Look For 

Are biotech penny stocks on your buy list right now The post Buying Biotech Penny...
By PennyStocks - 11 weeks ago

Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript
Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript

INO earnings call for the period ending September 30, 2022.
By The Motley Fool - 11 weeks ago

Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates
Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates

Inovio (INO) delivered earnings and revenue surprises of 48.28% and 3,880%, respectively, for the quarter...
By Zacks Investment Research - 11 weeks ago

What's Going On With Inovio Pharmaceuticals Stock Tuesday After Hours
What's Going On With Inovio Pharmaceuticals Stock Tuesday After Hours

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading marginally lower by 0.93% to $2.12 after...
By Benzinga - 11 weeks ago

Best Penny Stocks To Buy? 7 Short Squeeze Stocks To Watch Now
Best Penny Stocks To Buy? 7 Short Squeeze Stocks To Watch Now

Short squeeze stocks to watch right now. The post Best Penny Stocks To Buy? 7...
By PennyStocks - 12 weeks ago

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022

Upgrades For AnaptysBio Inc (NASDAQ:ANAB), Guggenheim upgraded the previous rating of Neutral to Buy. AnaptysBio...
By Benzinga - 12 weeks ago